Side effects of depot fluphenazines.
D000380:Agranulocytosis / Q000139:chemically induced; D001463:Barbiturates / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001590:Benztropine / Q000627:therapeutic use; D001712:Biperiden / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000009:adverse effects*; D003863:Depression / Q000139:chemically induced; D003975:Diazepam / Q000627:therapeutic use; D004347:Drug Interactions; D005132:Eye Manifestations; D005227:Fatty Acids / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy; D012640:Seizures / Q000139:chemically induced; D012877:Skin Manifestations
D001463:Barbiturates; D003692:Delayed-Action Preparations; D005227:Fatty Acids; D001712:Biperiden; D001590:Benztropine; D003975:Diazepam; D005476:Fluphenazine